PRESIDENT AND CEO, XENCOR
United States Biopharmaceuticals 2019 Pre-Release Edition
Powered by its XmAb antibody engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat autoimmune disorders, cancer, asthma and allergic diseases.